AI-generated summary
The authors report a triple-blind randomized trial of 46 women with dysphonia, comparing voice therapy plus active infrared laser to voice therapy plus placebo laser, with 39 completing the 8-week analysis. Both groups improved, and there was no significant difference in the primary perceptual severity outcome or in functional, acoustic or self-assessment measures. The active laser group showed a significant difference in vocal fold edge contour on laryngeal imaging, which the authors describe as a localized morphological change without a functional advantage.
- Participants
- 46
- Who or what was studied
- Women aged 18 to 60 years with dysphonia (behavioral dysphonia)
- Wavelengths
- 808 nm
- Limits stated in the abstract
- Only 39 of 46 enrolled women completed the per-protocol analysis, and the abstract reports no detail on the handling of dropouts.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 808 nm
- Power
- 100 mW
- Total energy
- 30 J
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Randomized controlled trial, Photobiomodulation, Laser, Primary outcome, Placebo-controlled, Control group. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.